William Jackson

William Jackson is co-chair of Goodwin Procter LLP’s Washington D.C. office, a partner in the firm’s Complex Litigation & Dispute Resolution practice and is a member of the firm’s Life Sciences Disputes group. His practice focuses on primarily on the life sciences and healthcare sectors. He has successfully represented both plaintiffs and defendants in intellectual property cases, class actions, contractual disputes, and other high-stakes commercial matters before federal courts, state courts, and domestic and international arbitration tribunals. In addition to representing clients in litigation, he often provides litigation risk analysis, counseling, and strategic advice.  Mr. Jackson has litigated, arbitrated, mediated, and counseled clients in a wide variety of industries including asset management, commercial banking, computer software, healthcare, healthcare technology, hedge funds, investment banking, payment systems, petrochemical and petrochemical services, pharmaceutical manufacturing, private equity, retail sales, and telecommunications.

His experience includes:

• Acting as co-lead trial counsel in a bench trial for a pharmaceutical company against a competitor in a dispute involving multiple patents as well as theft of trade secret claims in connection with an inhaled pharmaceutical product
• Serving as lead counsel for Silicon Valley startup against a pharmaceutical benefit manager in contract, statutory, and tort claims valued at over $600 million
• Served as co-lead trial counsel for a pharmaceutical manufacturer in Hatch-Waxman litigation against a generic competitor; the client’s victory in the case resulted in the company’s market cap increasing by more than $1 billion the day the decision was announced
• Acted as counsel to a leading healthcare technology company in connection with several litigations, as well as numerous intellectual property and related business matters
• Served as lead counsel for international software company in investigation by U.S. Government into $400 million in alleged overbillings; resulted in U.S. Government terminating investigation without liability
• Represented a telecommunications company in parallel foreign and domestic litigations involving allegations of securities fraud and malfeasance
• Served as counsel to an engineering company in a contract dispute involving an international petrochemical pipeline
• Represented an international private equity fund in connection with control of a foreign bank, as well as investigations into allegations of fraud, embezzlement, and money laundering
• Represented foreign investors in an international arbitration involving control and ownership of a Swiss corporation
• Defended a client in both civil and criminal antitrust actions involving the transportation and installation of deepwater offshore oil and gas platforms
• Represented an advertising company against a major grocery retailer in a breach of contract action
• Represented an international trading company against an international oil and gas corporation over the rights to an oil project in the Middle East

Prior to joining Goodwin, Mr. Jackson was most recently a partner at Boies Schiller Flexner LLP, where he began his legal career. He also previously taught negotiation and alternative dispute resolution at Harvard Law School, and was a lecturer on Law at Stanford Law School.